Today, Sanofi, alliance partner Regeneron and the atopic dermatitis community recognize the first Atopic Dermatitis Day. The goal behind this global event is to give a voice to patients, caregivers and their families to further understanding about the true burden of atopic dermatitis.
Atopic dermatitis (AD), a form of eczema, is a chronic inflammatory condition with symptoms often appearing as a rash on the skin.1,2,3,4 Moderate-to-severe atopic dermatitis is characterized by rashes often covering much of the body, and can include intense, persistent itching and skin dryness, cracking, redness, crusting, and oozing.
“Moderate-to-severe AD can be debilitating, both physiologically and psychologically,” said Bill Sibold, Executive Vice President, Sanofi Genzyme. “We are proud to join the global atopic dermatitis community in recognizing the first Atopic Dermatitis Day, which will help raise awareness about this chronic, often overlooked condition and increase the understanding of AD as more than just a skin condition.”
To support Atopic Dermatitis Day, Sanofi and Regeneron have released a heartfelt video that reflects the courage and resilience of those living with moderate-to-severe atopic dermatitis. For each view, retweet or Facebook share of the video on Sanofi, Sanofi Genzyme or Regeneron social channels using the hashtag #ChangeAD, Sanofi Genzyme and Regeneron will donate $1 to the International Alliance of Dermatology Patient Organizations to support atopic dermatitis education and awareness around the world.
- Eichenfield et al. Guidelines of Care for Atopic Dermatitis. AAD 2014, pp. 118.
- Guideline to treatment, European Dermatology Forum. https://www.euroderm.org/home/Guidelines/EDF-Guidelines.html. Accessed June 2018.
- Gelmetti and Wolleberg, BJD 2014, Atopic dermatitis- all you can do from the outside. Page 19.
- National Institutes of Health (NIH). Handout on Health: Atopic Dermatitis (A type of eczema) 2014. https://www.niams.nih.gov/health-topics/atopic-dermatitis#tab-overview. Accessed June 2018.